CKS2, regulated by METTL3, contributes to osteosarcoma progression in an IGF2BP1-dependent manner
{{output}}
Background: Emerging evidence implicates N6-methyladenosine (m6A) RNA modification in osteosarcoma (OS) pathogenesis, but the downstream effectors and regulatory networks remain not fully elucidated. Cyclin-dependent kinase subun... ...
